JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (1994) 143, R5-R8       DOI: 10.1677/joe.0.143R005
© 1994 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, M. J.
Right arrow Articles by Clark, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, M. J.
Right arrow Articles by Clark, C. L.

EVIDENCE FOR A NOVEL SOURCE OF RELAXIN: ATRIAL CARDIOCYTES

 Michael J. Taylor and Cheryl L. Clark

Antibody-directed, complement-induced erthrocyte lysis (reverse hemolytic plaque assay) around atrial cardiocytes was used to determine whether this cell type possesses the capacity to secrete the insulin-like hormone relaxin. After 2h of incubation, 33 ± 4% (n = 3) of cardiocytes derived from the atria of neonatal rats secreted detectable amounts of immunoreactive relaxin (i.e. formed plaques) when cultured in monolayers. Increased culture time of cardiocytes failed to increase the fraction of cardiocytes that secreted relaxin. The cumulative amount of relaxin secreted after 3h of incubation (plaque area) was 31% greater (P < 0.05) than the amount of hormone present after lh of incubation, evidence of sustained peptide secretion by cultured cardiocytes. These data suggest that the source of the endogenous ligand for the specific and high-affinity relaxin receptors located in rat atria is the atrial cardiocyte itself. Therefore, relaxin may act via autocrine and/or paracrine routes to regulate cardiovascular structure and/or function.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
L. Formigli, F. Francini, A. Tani, R. Squecco, D. Nosi, L. Polidori, S. Nistri, L. Chiappini, V. Cesati, A. Pacini, et al.
Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C795 - C804.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Conrad and J. Novak
Emerging role of relaxin in renal and cardiovascular function
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C Fisher, C Berry, L Blue, J J Morton, and J McMurray
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure
Heart, August 1, 2003; 89(8): 879 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
X.-J. Du, C. S Samuel, X.-M. Gao, L. Zhao, L. J Parry, and G. W Tregear
Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype
Cardiovasc Res, February 1, 2003; 57(2): 395 - 404.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. A. Parsell, J. Y. Mak, E. P. Amento, and ElaineN. Unemori
Relaxin Binds to and Elicits a Response from Cells of the Human Monocytic Cell Line, THP-1
J. Biol. Chem., November 1, 1996; 271(44): 27936 - 27941.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.